SlideShare a Scribd company logo
Edward B. Fohrman M.D
Assistant Professor, Department of Anesthesiology
Northwestern University, Feinberg School of Medicine
POSTANESTHESIA RECOVERY
CASE
▪ 55 y.o. male s/p robotic prostatectomy
otherwise uneventful…
▪ Surgery is over
▪ Volatile agent is off
▪ Reversal given
▪ HOW DO U KNOW WHEN PT. IS READY FOR
EXTUBATION???
EXTUBATION CRITERIA?
▪ PaO2/FiO2 > 300
▪ PaCO2 < 50 mmHg
▪ Vd/Vt < 0.6
▪ RR < 35
▪ Vt > 5 ml/kg
▪ NIF > (-20 mm H20)
▪ TOF ratio > 0.9
▪ Clinical Strength (5 sec head lift)
▪ Mental Status c/w ability to maintain airway
▪ No Airway Edema/Vocal cord paralysis or other cause of airway
obstruction
▪ Hemodynamic Stability
When to transfer to PACU?
▪ ABC’s
▪ Patent or secure airway
▪ Adequate Oxygenation & Ventilation
▪ Hemodynamically stable
O2 During Transport?
1) <93% after extubated in OR
2) Unconscious
3) Age > 60
4) Wgt > 100 kg
5) Pulmonary disease
6) Difficult airway
7) OSA
8) Surgery: Abd., Thoracic, Neuro, Cardiac, ENT
9) N2O (avoid diffusion hypoxia)
10) SpO2 < 93% upon arrival to PACU
Probably NOT necessary in LOW RISK patient
population…
“Favor using O2 in anyone who’s physiology would
be negatively affected by even a brief hypoxemic
episode”
How much O2 R U giving?
Each liter of Nasal Cannula O2 increases
FiO2 by 3 - 4%
(Starting from room air 21%)
Nasal cannula does not suppress
respiratory drive even in COPD
It is impossible to deliver more than 40%
FiO2 with N.C. due to limitations in flow
dynamics
*DELIVERY OF 100% O2 can only be
achieved with INTUBATION!!!
Short of this, the highest O2 delivery can
be achieved with a high flow, 10L
“Nonrebreather” Face mask ≈ 90% FiO2
Miller’s Anesthesia 6th Ed. 2005
Admission to the PACU
▪ Patient’s name & age
▪ Surgical procedure/Anes type
▪ Coexisting medical probs
▪ Allergies
▪ Fluids: EBL, IVF, UOP
▪ Anes/Surgical complications
▪ (difficult airway?)
▪ Special requests: meds, labs, x-rays
▪ Lines/Location (a-line, iv’s, epidural)
Early Post-Op Physiologic Disorders
▪ Upper Airway
Obstruction
▪ Arterial Hypoxemia
▪ Hypoventilation
▪ Hypotension
▪ Hypertension
▪ Cardiac Dysrhythmias
▪ Oliguria
▪ Bleeding
▪ Hypothermia
▪ Agitation/ Emergence
Delirium
▪ Delayed Awakening
▪ Nausea & Vomiting
Case
▪ 52 y.o. male s/p C4-6 ACDF brought to
PACU after extubation
▪ 20 min later to inform u patient is
tachypneic with SpO2 91
▪ DDX?
▪ What else do you want to know?
▪ What’s your next move???
Case
▪ 8 y.o. male s/p inguinal hernia repair brought to PACU
after deep extubation
▪ The patient suddenly bucks and begins to desaturate
rapidly…DDX? Treatment?
▪ What is Stage 2 anesthesia and why is it significant?
▪ How do you know when a patient is in stage 2
anesthesia?
Upper Airway Obstruction
▪ Loss of pharyngeal muscle tone
▪ Obstructive Sleep Apnea (OSA)
▪ Laryngospasm
▪ Deep extubation? / Tx?
▪ Airway edema
▪ ↑IVF, ↑EBL, ↑Duration, Prone position
▪ Surgery of tongue, pharynx, neck, thyroid, CEA
▪ CUFF TEST
▪ Neck hematoma
▪ Monitor airway patency during transport –
(Look, Listen, Feel)
Residual Neuromuscular Blockade
▪ Assessment of adequate reversal?
▪ TOF, DBS, Clinical sx
▪ What factors increase risk of residual block?
▪ Drugs – Volatiles, local, Antiarrhythmics, Antibiotics, Corticosteroids,
CCB’s, Dantrolene, Lasix, BCP’s
▪ Metabolic Physiologic states - ↑Mg, ↓Ca, Hypothermia, acidosis, liver/
renal failure, Myasthenia Gravis, Extremes of age
▪ Prolonged Depolarizing block
▪ Atypical pseudocholinesterase, Phase II block, Pregnancy, Echothiophate
(irreversible), Edro, Neo, Pyrido (reversible)
Classification of NMB’s
Depolarizing
▪ Succinylcholine
Nondepolarizing
➢ Short Acting
➢Mivacurium
➢Rapacuronium
➢ Intermediate Acting
➢Rocuronium
➢Vecuronium
➢Cisatracurium
➢Atracurium
➢ Long Acting
➢Pancuronium
Case
▪ You just “deep” extubated your patient to avoid
bucking on the tube after an otoplasty. As you are
moving the patient to the gurney, the patient
bucks and coughs and begins to turn blue.
▪ More good news…your IV was inadvertantly pulled
out during the move and is now dripping on the O.R.
floor…
▪ What’s the problem and how are you going to save
the day?
Succinylcholine
• 2 Ach molecules linked by methyl groups
• Agonist action binds the alpha subunit and leads to muscle contraction and
refractory period
• Depolarizing block also called Phase I block
• Intubating dose: 1-1.5mg/kg (ED95 = 0.3mg/kg)
• Onset 30-60 secs and duration 5-10 minutes
• Defasciculating dose of nondepolarizer
• (5-10% of ED95 2-4 min prior) must increase sux dose by 70%
•Repeated doses > 3-5mg/kg >>> Phase II block
•Serum potassium (K+) by 0.5 to 1 mEq/L
• EJnAchR’s increase K+ ???
Why Sux is unique?
▪ The only Depolarizing blocker used
clinically today
▪ Most rapid onset of any other NMB
▪ Most rapid recovery/offset of any NMB
▪ Most significant degree of vocal cord
paralysis/BEST intubating conditions
▪ Only NMB with rapid effects when given
I.M. in cases of no IV access…IM dose?
Each of the following patients requires
urgent intubation…what do they all
have in common???



75 y.o. male s/p ischemic CVA 3 weeks ago with
residual left hemiparesis



21 y.o. female PMH - MVA 4 years ago with
incomplete T4 level – urosepsis/pneumonia and
SpO2 89%



18 y.o. male s/p GSW to head, in barb coma w/
vecuronium gtt x 7 days who was inadvertantly
extubated by the RN…

Sux: Adverse side effects
▪ Hyperkalemia!!!
▪ Note: 1mg/kg Sux does NOT increase ICP (Kovarik et al.
Anesthesia&Analgesia, 1994;78:469-73
▪ Myoglobuinuria – Malignant Hyperthermia (MH)
▪ Cardiac dysrhythmias (esp. 2nd dose!)
▪ Sinus brady, Jct brady, Sinus arrest
▪ Fasciculations
▪ Myalgia (especially in outpatients)
▪ Increased intraocular pressure (not more than bucking)
▪ Increased intragastric pressure
▪ Trismus - Masseter muscle rigidity common in peds (4%)
▪ Associated with subsequent development of MH
“Extrajunctional Receptors”
Normal
Denervation
Effect of Sux on denervated muscle
Martin and Richtsfeld, Anesthesiology, 2006;104:158-69
Up/Down Regulation of nAChR
Martin and Richtsfeld, Anesthesiiology, 2006;104:158-69
▪ 22 y.o. 70 kg. male without significant
PMH/PSH undergoes a RSI for acute
appendicitis. 10 min after 1mg/kg of sux,
the patient receives a 30mg dose of ROC.
▪ The case goes well and the surgeon begins
skin closure.
▪ TOF reveals that the patient still has no
twitches 1 hour after the last dose of
ROC….WHY?
CASE
Atypical Cholinesterase
▪ Check TOF after sux, (before NDNMB)
▪ Dx after a patient has a prolonged response to
sux or mivacurium (>1hour)
▪ Dibucaine Number
▪ Dibucaine – amide local anesthetic
▪ Inhibits normal enzyme by 80%
▪ Inhibits abnormal enzyme by only 20%
Variants of Plasma Cholinesterase and Duration of action of
Succinylcholine
Variants of Plasma
Cholinesterase Incidence
Dibucaine Number
(% Inhibition of
enzyme activity)
Duration of
succinylcholine
induced
neuromuscular
blockade (min)
Homozygous
Typical
Normal 70-80 5-10
Heterozygous 1 in 480 50-60 20
Homozygous
Atypical
1 in 3200 20-30 60-180
Stoelting & Miller, Basics of Anesthesia. 2007
Martin and Richtsfeld, Anesthesiology, 2006;104:158-69
Arterial Hypoxemia
▪ R > L Shunt
▪ Atelectasis
▪ V/Q Mismatch
▪ ↓FRC
▪ CHF
▪ Pulmonary Edema
▪ Alveolar Hypoventilation
▪ Drugs: (NMBs, Narcotics,Volatiles)
▪ Increased CO2 production/
COPD
▪ Suboptimal ventilatory
mechanics
▪ Aspiration
▪ PE
▪ PTX
▪ ↑O2 Consumption
▪ Shivering
▪ Sepsis
▪ TRALI
▪ ARDS
▪ Advanced age
▪ Obesity
▪ Diffusion Hypoxia
6 Causes of Arterial Hypoxemia
1. Low FiO2
2. Hypoventilation
▪ Muscle relaxants, narcotics, pain/splinting
▪ PAO2 = FiO2(PB760-PH2047) – (PCO2/RQ)
Arterial Hypoxemia
3. Shunt V/Q = 0 (Absolute shunt)
▪ perfusion without ventilation
▪ PTX, bronchial intubation/single lung ventilation, R>L
cardiac shunt, ARDS/sepsis, liver failure, AVM, atelectasis,
pneumonia/mucous plugging, pulmonary contusion,
bronchospasm, CHF
▪ Shunted blood is NOT exposed to alveoli, thus O2
unresponsive for shunt > 30%
▪ Shunt fraction = Qs/Qt = CcO2-CaO2/CcO2-CvO2
▪ 2 sources of normal shunt: Bronchial arteries and
thebesian veins. (Normally 2-5%)
Arterial Hypoxemia
4. V/Q Mismatch V/Q = ∞
Dead space: ventilation without perfusion V/Q>1
i.e. Pulmonary Embolus
V/Q matching optimally should be 1:1
Hypoxic Pulmonary Vasoconstriction (HPV)
5. Diffusion defects
Advanced pulmonary disease, pulmonary edema, ARDS
6. ↑Venous Admixture
(Low cardiac output states)
O2 Delivery = O2 content x Cardiac Output
O2 Content = 1.34 x Hgb x SaO2 + (PaO2 x 0.003)
Decreased CO, ↑ O2 consumption, Anemia,
Hgb dysfct.
Shunt – Response to O2
▪ Increasing FiO2 from room
air to 100% results in a
large increase in PaO2
when the shunt fraction is
small; however,
oxygen will have
little effect on PaO2
in patients with a
large shunt fraction
Miller’s Anesthesia 6th Edition, 2005
Case
▪ 38 y.o. female s/p scoliosis repair is
brought to the ICU intubated.
▪ You note SpO2 of 89% and absent BS on
the Left chest
▪ You ask for a stat CXR for line placement
(left SCV cordis)
▪ What’s your next move???
Pulmonary Edema
▪ Fluid Overload
▪ Iatrogenic: Large IVF, Blood transfusions (TACO)
▪ ESRD/CRF
▪ Cardiogenic/CHF
▪ MI, Arrhythmia, Valvular lesion
▪ Euvolemic
▪ ARDS
▪ Catecholamine surge
▪ Neurogenic/SAH
▪ TRALI (up to 6hr post tx delay, leukopenia)
▪ Negative Pressure Pulmonary Edema
Reintubation in PACU?
▪ PaO2/FiO2 ratio < 300
▪ Respiratory rate > 35 breaths/minute
▪ Tidal Volume Vt < 5 cc/kg
▪ Vital capacity <15ml/kg (adults) <10ml/kg (peds)
▪ Negative inspiratory force of < -20 mmHg
▪ PaO2 < 70 mmHg on 40% FiO2
▪ PaCO2 > 55-60 mmHg (except chronic CO2 retainers i.e.COPD)
▪ Alveolar-arterial (A-a) gradient > 350 mmHg on 100% FiO2
▪ Dead Space (VD/VT) > 0.6
▪ Hemodynamic instability?
▪ WHAT DOES THE PATIENT LOOK LIKE???
Case
▪ 68 y.o. male s/p RLL Lobectomy under GA,
Thoracic epidural, Dbl lumen ETT, now
extubated to PACU
▪ BP 70/40, HR 120, SpO2 93%
▪ DDX?
▪ What’s your next move???
HYPOTENSION
BP = CO x SVR
CO = SV x HR SVR = MAP- CVP
CO
Preload
Afterload
Cardiac Contractility
Hypotension
▪ ↓Intravascular Volume (Preload)
▪ (PCWP<5-10mmHg) with normal CI (2.5-4.0)
▪Bleeding!
▪Bleeding!!
▪Bleeding!!!
▪3rd Spacing
▪Insensible losses
Hypotension
▪ ↓Cardiac Output (Intrinsic pump failure)
▪CO = HR x SV (CI < 2.5)
▪ MI
▪ Cardiomyopathy
▪ Valvular Dz
▪ Pericardial Dz
▪ Tamponade
▪ Dysrhythmias
▪ PE
▪ Tension PTX
▪ Drugs (Beta Blockers, CCBs)
Hypotension
▪ ↓Systemic Vascular Resistance (Afterload)
▪ SVR = (MAP-CVP/CO) x 80 (900 to 1400 dynes/
sec/cm-5)
▪ Sepsis / SIRS
▪ Anaphylaxis
▪ Spinal Shock (SCI, Epidural/High Spinal)
▪ Adrenal Insufficiency
Case
▪ 68 y.o. male s/p Left CEA under GA now
extubated to PACU
▪ BP 198/100, HR 61, SpO2 97%
▪ DDX?
▪ What’s your next move???
Hypertension
▪ A-line transducer level?
▪ Emergence Excitement?
▪ Arterial Hypoxemia
▪ Enhanced Sympathetic Tone
▪ PAIN, PAIN, PAIN
▪ Hypoventilation/Hypercapnia
▪ Autonomic Hyperreflexia, Carotid surgery
▪ Bladder distention/ Gastric distention
▪ Essential HTN – Preop
▪ Hypervolemia/Fluid Overload
▪ Shivering
▪ Drugs/ Drug Rebound
▪ ↑ ICP
▪ Thyrotoxicosis, Pheochromocytoma
Cardiac issues in PACU
▪ Risk factors for CAD
▪ Smoking
▪ HTN
▪ Hypercholesterolemia
▪ Diabetes Mellitus
▪ Obesity
▪ Physical Inactivity
▪ Family History
▪ (1st order relative prior to age 55)
Identify patients at risk!
ECG ∆’s in PACU
▪ Low Risk Patient ?
▪ Age < 45
▪ No known Cardiac History
▪ Only 1 Cardiac Risk Factor
▪ Post op ST ∆’s = MI? Usually NOT
▪ Usually benign and do not require more than routine PACU observation
unless associated dysrhythmia and/or hemodynamic instability
DON’T DO A MILLION $ Work UP!!!
ECG ∆’s (High Risk)
▪ Who is High Risk?
▪ Post op ST and T ∆’s may be significant even in the absence
of typical sx
▪ 12 lead ECG (vs. preop ECG)
▪ Serial Troponin-I (cTni), CBC, Chem, ABG
▪ O2, NTP/NTG, Beta Blockade
▪ If BP unstable
▪ consider re-intubation/echo/PA catheter/Inotropes
▪ Notify primary service/ discuss your concerns
▪ Cardiology consult/ follow-up
▪ Disposition – Tele, ICU, floor?
Cardiac Dysrhythmias
▪ Hypoxemia
▪ Hypercarbia
▪ Volume Shifts/Fluid Overload
▪ Myocardial Ischemia
▪ Electrolyte Abnormalities
▪ Acidosis
▪ Anemia
▪ Pain, Agitation,
Hypothermia
▪ HTN
▪ Preoperative Cardiac
Dysrhythmia
▪ Drugs/ Withdrawal
▪ Digoxin Toxicity
▪ Anticholinesterases
▪ Anticholinergics
▪ PE
▪ PTX/Line placement
▪ SIRS
▪ MH
▪ Thyroid storm/Pheo
Case
▪ 44 y.o. male patient s/p appy
▪ 5 minutes after giving report, the patient’s HR
is 40…
▪ What else do you want to know?
▪ What are you going to do?
Atrial Dysrhythmias
▪ Noncardiac Surgery (10%)
▪ Cardiothoracic Surgery (25-30%)
▪ Associated with longer hospital stay and higher
mortality
▪ Electrical Cardioversion vs. ctrl Ventricular response
– CCB, β-Blockade, Amiodarone
▪ Vagal maneuvers, adenosine to distinguish between
SVT and A-fib/flutter
Ventricular Dysrhythmias
▪ PVC’s, Ventricular Bigeminy are common, but
rarely degenerate into V-tach
▪ PVC’s may just reflect ↑ sympathetic stim.
(hypercapnia, intubation)
▪ Multifocal PVC’s vs. Unifocal PVC’s?
▪ Consider ABG, CBC, Chem, cTni if suspect
myocardial ischemia – Torsades, QT
prolongation?
▪ Electrical Cardioversion vs. Amiodarone
Case
▪ 81 y.o. male s/p Right Hip Pinning under
GA, now extubated to PACU
▪ Mr. Cartman is confused…
▪ DDX?
▪ What’s your next move?
Delirium
▪ An acute change in cognition or
disturbance of consciousness that
cannot be attributed to a
preexisting medical condition ,
substance intoxication, or
medication.
▪ 10% Incidence: > 50 y.o.
undergoing elective surgery up to
POD #5
▪ Higher incidence (30%) after Hip
ORIF and Bilateral TKR
Risk Factors: Post-Op Delirium
▪ Advanced age
▪ Preoperative cognitive impairment
▪ Decreased functional status
▪ ETOH abuse
▪ History of delirium
Management of Post-Op Delirium
▪ Vitals!
▪ Patient Safety
▪ Restraints
▪ Physical ( soft restraint/full restraint)
▪ Chemical (Versed, Physostigmine, Antipsychotics
(Haldol)
▪ Even if it means Reintubation!
▪ Work-UP Etiology…
DDX Delirium
▪ Arterial Hypoxemia
▪ Preexisting Cognitive Disorder
▪ Dementia, Parkinson’s vs. conversion rxn
▪ Hypoventilation/Hypercapnia
▪ Metabolic Derangements
▪ Renal/Hepatic insufficiency, Acidosis, Electrolyte abnormalities
▪ Drugs
▪ Anticholinergics, BDZ’s, Opioids, β-Blockers, Reglan
▪ CNS
▪ Ischemic/Hemorrhagic CVA, Seizures
▪ Infection/SIRS
▪ Emergence Excitement:
▪ 30% of peds, peak age 2-4 y.o.
Case
▪ 49 y.o. male s/p ex-lap for perforated
diverticulitis under GA, now extubated to
PACU
▪ Patient has no urine output from the
foley
▪ DDX?
▪ What’s your next move?
Oliguria
▪ Most commonly “pre-renal” from depletion of intravascular
volume
▪ Usually responds to a 500-1000ml bolus
▪ Check Hct to rule out surgical bleeding
▪ d/w surgeon/?check bladder pressure to rule out intra-
abdominal htn
▪ Intra-abdominal Pressure > 30cm H2O can impair renal
perfusion
▪ Value of fractional excretion of sodium (FeNa) is limited in the
PACU and confounded by diuretics
▪ In cases where the patient’s volume status and/or cardiac
function is in question (MI, CHF, SIRS), consider placing a PA
Catheter/or obtaining an echocardiogram
Renal Dysfunction
▪ Oliguria (<0.5 ml/kg/hr)
▪ Preop vs. Intraop vs. Postop
▪ Usually multifactorial (i.e. Preexisting
CRI confounded by an intraoperative
insult)
▪ Focus on “treatable causes” in PACU
Classification
• Prerenal
• Renal
• Postrenal
Postoperative Oliguria
▪ Prerenal
▪ Hypovolemia
▪Bleeding, Bleeding, Bleeding
▪3rd Spacing, Insensible losses
▪Inadequate volume resuscitation
▪ Hepatorenal syndrome
▪ Low Cardiac Index (MI, CHF,)
▪ SIRS
▪ Renal Vascular Obstruction/
Disruption
▪ Abdominal Compartment Syndrome
Postoperative Oliguria
▪ Renal
▪ Ischemia (ATN)
▪ Contrast/IVP Dyes
▪ Rhabdomyolysis (Alkalinize
urine/mannitol)
▪ Tumor lysis
▪ Hemolysis
Postoperative Oliguria
▪ Postrenal
▪ Surgical injury to Ureter(s)
▪ Ureteral obstruction (Stone,
Clots)
▪ Mechanical (Foley Catheter
obstruction/Malposition
Body Temperature & Shivering
▪ Postoperative shivering
▪ Incidence: 5%→65%
▪ Mechanism
▪ Hypothermia- thermoregulatory center
▪ Normothermia- more rapid recovery of spinal cord function,
uninhibited spinal reflexes→ clonic activity
▪ Treatment
▪ Identification of hypothermia by core body temp
▪ Forced air warmers
▪ Opioids, Clonidine, Meperidine (most effective)
Body Temperature & Shivering
▪ Clinical Effects
▪ Increases O2 consumption and CO2 production
▪ Increased CO, HR and BP
▪ Inhibition of platelet function, coagulation factor activity
and drug metabolism
▪ Exacerbates postoperative bleeding, prolongs neuromuscular
blockade, and may delay awakening
▪ Prolonged PACU stay
▪ Long Term: increased incidence of myocardial ischemia/
infarction, delayed wound healing, increased perioperative
mortality
PONV
▪ Incidence: 10%→80%
▪ Delayed Discharge
▪ Unanticipated Admission
▪ Pulmonary Aspiration
▪ Post-operative discomfort
PONV RISK
▪ High Risk Patients
▪ Female
▪ History of Motion
sickness/PONV
▪ Nonsmoker
▪ Intra/Postoperative
opioids
▪ Peds
▪ Other Risk Factors
▪ Obesity
▪ Anxiety
▪ Gastroparesis/ Gastric
distension
▪ GERD
▪ Dehydration
▪ Type of Surgery (eye muscle,
middle ear, laparoscopic,
Breast, Plastics)
▪ Anesthetic Drugs (Volatile
0-2hrs, N2O, NMB Reversal?)
Consensus Guidelines for Managing PONV, Anesth & Analg 7/2003
PONV
▪ For every 30 minutes of inhalational
anesthesia, there is a 60% increase in PONV
risk…
Consensus Guidelines for Managing PONV, Anesth & Analg 7/2003
PONV
▪ Serotonin (5-HT3) Antagonists (Ondansetron)
▪ Effective when given 30min before end of case
▪ Corticosteroids (Dexamethasone)
▪ Replaced droperidol for 1st line prophylaxis, unknown
mechanism (reduce prostaglandins)
▪ Anticholinergics (Scopolamine)
▪ Antihistamines (Hydroxyzine)
▪ Prokinetic (Promethazine)
▪ Butyrophenones (Droperidol)
▪ Very effective, FDA Warning 6/2001, 6 hour monitoring for
cardiac dysrhythmia (torsades de pointes)
Treatment PONV
▪ Low Risk Patients
▪ Dexamethasone prophylaxis
▪ Moderate Risk Patients
▪ Dexamethasone prophylaxis
▪ Serotonin Antagonists
▪ High Risk Patients
▪ Dexamethasone prophylaxis
▪ Seratonin Antagonists
▪ Prokinetic
▪ Very High Risk Patients
▪ Multimodal approach
▪ Aggressive IV Fluid
▪ Combination pharmacotherapy
▪ REGIONAL ANESTHESIA when possible
▪ TIVA
▪ Avoid: Opioids, inhalational agents/N2O, reversal
agents
Bleeding Abnormalities
Test Normal Value Abnormality
Platelet Count >150,000 cells/mm3 Dilutional, DIC
Bleeding Time 3-10 min Platelet-inhibiting Rx
Prothrombin Time 12-14 sec DIC, Vit K Def, Liver Dz,
Coumadin
Partial Thromboplastin Time 25-35 sec Factor V and VIII Def,
Heparin, Heophilia
Fibrinogen 200-400 mg/dL DIC
Fibrin Split Products <4 µg/ml DIC
TEG N/A Platelet and clotting factor
deficiencies
Platelet Fct Assay N/A Plt Adhesion & Aggregation
Case
▪ You are the PACU resident of the week
and the RN calls re:
▪“My patient in slot 12 isn’t
waking up!”
▪ What else do you want to know?
▪ DDX?
Delayed Awakening
▪ Possible explanations…
▪ Pharmacological
▪ Residual Drug Effect (Opioids, BDZ, anticholinergics)
***Most frequent cause
▪ Chemical (Metabolic)
▪ Hypoxemia, Hypercarbia, Hypoglycemia, Electrolyte
abnormalities
▪ Physical
▪ Hypothermia (Temp < 33°C), Air Embolism
▪ Neurologic
▪ Increased ICP, Sz/Postictal, Hysteria?
Delayed Awakening
▪ Evaluation
▪ VITAL SIGNS!!!
▪ Neurologic Exam
▪ ABG (oxygenation and ventilation)
▪ Additional labwork
▪ Electrolytes, glucose, etc..
▪ Radiographic procedures (CT)
Delayed Awakening
▪ Analgesic
▪ Opioids → Naloxone (20-40 µg increments)
▪ Short acting, reversal of analgesia, hypertension, arrhythmias, delerium
▪ Anesthetic - Hypnotic
▪ Benzodiazepines → Flumazenil (0.2mg IV over 15
sec, 0.3mg IV over 30 sec, 0.5mg IV over 30 sec) Side effect/Risk of
seizures
▪ Akinetics
▪ Muscle Relaxants → Neostigmine
Modified Aldrete Score D/C Criteria
QUESTIONS?

More Related Content

What's hot

GEMC: Thyroid Storm: Resident Training
GEMC: Thyroid Storm: Resident TrainingGEMC: Thyroid Storm: Resident Training
GEMC: Thyroid Storm: Resident Training
Open.Michigan
 
Endocrine hypertension
Endocrine hypertensionEndocrine hypertension
Endocrine hypertension
Dr. Lala Shourav Das
 
Stroke in Young
Stroke in YoungStroke in Young
Stroke in Young
Yasser Alzainy
 
Syncope
SyncopeSyncope
secondary hypertension
secondary hypertensionsecondary hypertension
secondary hypertension
Krishna Vasudev
 
Hypertensive Encephalopathy and Emergencies
Hypertensive Encephalopathy and EmergenciesHypertensive Encephalopathy and Emergencies
Hypertensive Encephalopathy and Emergencies
sazzad92
 
Aproach to syncope
Aproach to syncopeAproach to syncope
Aproach to syncope
Nurshawina Kamaludin
 
Anesthetic Management of a Patient with Peripartum Cardiomyopathy for LUCS
Anesthetic Management of a Patient with Peripartum Cardiomyopathy for LUCSAnesthetic Management of a Patient with Peripartum Cardiomyopathy for LUCS
Anesthetic Management of a Patient with Peripartum Cardiomyopathy for LUCS
Md Rabiul Alam
 
Nephrology - ARCHER USMLE STEP 3
Nephrology - ARCHER USMLE STEP 3Nephrology - ARCHER USMLE STEP 3
Nephrology - ARCHER USMLE STEP 3
Archer Review USMLE and NCLEX
 
preoperative cardaic evaluation for non cardiac surgery
preoperative cardaic evaluation for non cardiac surgerypreoperative cardaic evaluation for non cardiac surgery
preoperative cardaic evaluation for non cardiac surgery
guest0fe90c4e
 
SASH : Cerebrovascular disease - Stroke by Dr Georgina Child
SASH : Cerebrovascular disease  - Stroke by Dr Georgina ChildSASH : Cerebrovascular disease  - Stroke by Dr Georgina Child
SASH : Cerebrovascular disease - Stroke by Dr Georgina Child
SASH Vets
 
Hypertensive crisis
Hypertensive crisisHypertensive crisis
Hypertensive crisis
Maged Abulmagd
 
Management Of Intracranial Hemorrhages
Management Of Intracranial HemorrhagesManagement Of Intracranial Hemorrhages
Management Of Intracranial Hemorrhages
EM OMSB
 
A case of 100% blocked Right coronary artery
A case of 100% blocked Right coronary arteryA case of 100% blocked Right coronary artery
A case of 100% blocked Right coronary artery
Asif Alvi
 
Head injury
Head injuryHead injury
Head injury
Antara Banerji
 
RVD
RVDRVD
Anaesthesia for renal transplantation
Anaesthesia for renal transplantationAnaesthesia for renal transplantation
Anaesthesia for renal transplantation
Souvik Maitra
 
Anesthetic Aspects of Endocrine Surgery
Anesthetic Aspects of Endocrine SurgeryAnesthetic Aspects of Endocrine Surgery
Anesthetic Aspects of Endocrine Surgery
NC Association of Nurse Anesthetists
 
Peripartum cardiomyopathy
Peripartum cardiomyopathyPeripartum cardiomyopathy
Peripartum cardiomyopathyArchana Verma
 

What's hot (19)

GEMC: Thyroid Storm: Resident Training
GEMC: Thyroid Storm: Resident TrainingGEMC: Thyroid Storm: Resident Training
GEMC: Thyroid Storm: Resident Training
 
Endocrine hypertension
Endocrine hypertensionEndocrine hypertension
Endocrine hypertension
 
Stroke in Young
Stroke in YoungStroke in Young
Stroke in Young
 
Syncope
SyncopeSyncope
Syncope
 
secondary hypertension
secondary hypertensionsecondary hypertension
secondary hypertension
 
Hypertensive Encephalopathy and Emergencies
Hypertensive Encephalopathy and EmergenciesHypertensive Encephalopathy and Emergencies
Hypertensive Encephalopathy and Emergencies
 
Aproach to syncope
Aproach to syncopeAproach to syncope
Aproach to syncope
 
Anesthetic Management of a Patient with Peripartum Cardiomyopathy for LUCS
Anesthetic Management of a Patient with Peripartum Cardiomyopathy for LUCSAnesthetic Management of a Patient with Peripartum Cardiomyopathy for LUCS
Anesthetic Management of a Patient with Peripartum Cardiomyopathy for LUCS
 
Nephrology - ARCHER USMLE STEP 3
Nephrology - ARCHER USMLE STEP 3Nephrology - ARCHER USMLE STEP 3
Nephrology - ARCHER USMLE STEP 3
 
preoperative cardaic evaluation for non cardiac surgery
preoperative cardaic evaluation for non cardiac surgerypreoperative cardaic evaluation for non cardiac surgery
preoperative cardaic evaluation for non cardiac surgery
 
SASH : Cerebrovascular disease - Stroke by Dr Georgina Child
SASH : Cerebrovascular disease  - Stroke by Dr Georgina ChildSASH : Cerebrovascular disease  - Stroke by Dr Georgina Child
SASH : Cerebrovascular disease - Stroke by Dr Georgina Child
 
Hypertensive crisis
Hypertensive crisisHypertensive crisis
Hypertensive crisis
 
Management Of Intracranial Hemorrhages
Management Of Intracranial HemorrhagesManagement Of Intracranial Hemorrhages
Management Of Intracranial Hemorrhages
 
A case of 100% blocked Right coronary artery
A case of 100% blocked Right coronary arteryA case of 100% blocked Right coronary artery
A case of 100% blocked Right coronary artery
 
Head injury
Head injuryHead injury
Head injury
 
RVD
RVDRVD
RVD
 
Anaesthesia for renal transplantation
Anaesthesia for renal transplantationAnaesthesia for renal transplantation
Anaesthesia for renal transplantation
 
Anesthetic Aspects of Endocrine Surgery
Anesthetic Aspects of Endocrine SurgeryAnesthetic Aspects of Endocrine Surgery
Anesthetic Aspects of Endocrine Surgery
 
Peripartum cardiomyopathy
Peripartum cardiomyopathyPeripartum cardiomyopathy
Peripartum cardiomyopathy
 

Similar to Edward Fohrman | Postanesthesia Recovery

Pituitary tumors and Anaesthetic implications
Pituitary tumors and Anaesthetic implicationsPituitary tumors and Anaesthetic implications
Pituitary tumors and Anaesthetic implications
Dr. Agalya
 
Mellss anaesthesia for emergency surgery
Mellss anaesthesia for emergency surgeryMellss anaesthesia for emergency surgery
Mellss anaesthesia for emergency surgery
nur amalina aminuddin baki
 
SIN Toxicology Lecture by David Collins
SIN Toxicology Lecture by David CollinsSIN Toxicology Lecture by David Collins
SIN Toxicology Lecture by David Collins
SMACC Conference
 
Cardiac emergencies in children.pptx
Cardiac emergencies in children.pptxCardiac emergencies in children.pptx
Cardiac emergencies in children.pptx
Manish Chokhandre
 
Turp CASE FINAL.pptx
Turp CASE FINAL.pptxTurp CASE FINAL.pptx
Turp CASE FINAL.pptx
JeyRaj4
 
HCM Hypertrophic cardiomyopathy.pptx
HCM Hypertrophic cardiomyopathy.pptxHCM Hypertrophic cardiomyopathy.pptx
HCM Hypertrophic cardiomyopathy.pptx
desktoppc
 
Cardiology 1.3. Syncope - by Dr. Farjad Ikram
Cardiology 1.3. Syncope - by Dr. Farjad IkramCardiology 1.3. Syncope - by Dr. Farjad Ikram
Cardiology 1.3. Syncope - by Dr. Farjad Ikram
Farjad Ikram
 
ICU topics for Final FRCA
ICU topics for Final FRCAICU topics for Final FRCA
ICU topics for Final FRCAAndrew Ferguson
 
Congenital Heart Disease for Anaesthesia
Congenital Heart Disease for AnaesthesiaCongenital Heart Disease for Anaesthesia
Congenital Heart Disease for Anaesthesia
AnmolSrivastava74
 
Pulmonary embolism
Pulmonary embolismPulmonary embolism
Pulmonary embolism
salaheldin abusin
 
ECLAMPSIA
ECLAMPSIA ECLAMPSIA
ECLAMPSIA
ssuser9cd3f0
 
Hypertensive Crises.pptx
Hypertensive Crises.pptxHypertensive Crises.pptx
Hypertensive Crises.pptx
AbdirizakJacda
 
hypertensivecrises-221217080320-c743c113.pptx
hypertensivecrises-221217080320-c743c113.pptxhypertensivecrises-221217080320-c743c113.pptx
hypertensivecrises-221217080320-c743c113.pptx
SuhailRafik1
 
Hypertensive Crises.pptx
Hypertensive Crises.pptxHypertensive Crises.pptx
Hypertensive Crises.pptx
AbdirizakJacda
 
BPH case undergoing TURP
BPH case undergoing TURPBPH case undergoing TURP
BPH case undergoing TURP
tulsimd
 
ICU Topics for the Final FRCA
ICU Topics for the Final FRCAICU Topics for the Final FRCA
ICU Topics for the Final FRCAmeducationdotnet
 
Stroke
StrokeStroke
Pulmonary embolism
Pulmonary embolismPulmonary embolism
Pulmonary embolism
Khurram Wazir
 

Similar to Edward Fohrman | Postanesthesia Recovery (20)

Pituitary tumors and Anaesthetic implications
Pituitary tumors and Anaesthetic implicationsPituitary tumors and Anaesthetic implications
Pituitary tumors and Anaesthetic implications
 
Mellss anaesthesia for emergency surgery
Mellss anaesthesia for emergency surgeryMellss anaesthesia for emergency surgery
Mellss anaesthesia for emergency surgery
 
SIN Toxicology Lecture by David Collins
SIN Toxicology Lecture by David CollinsSIN Toxicology Lecture by David Collins
SIN Toxicology Lecture by David Collins
 
Cardiac emergencies in children.pptx
Cardiac emergencies in children.pptxCardiac emergencies in children.pptx
Cardiac emergencies in children.pptx
 
Turp CASE FINAL.pptx
Turp CASE FINAL.pptxTurp CASE FINAL.pptx
Turp CASE FINAL.pptx
 
HCM Hypertrophic cardiomyopathy.pptx
HCM Hypertrophic cardiomyopathy.pptxHCM Hypertrophic cardiomyopathy.pptx
HCM Hypertrophic cardiomyopathy.pptx
 
Cardiology 1.3. Syncope - by Dr. Farjad Ikram
Cardiology 1.3. Syncope - by Dr. Farjad IkramCardiology 1.3. Syncope - by Dr. Farjad Ikram
Cardiology 1.3. Syncope - by Dr. Farjad Ikram
 
ICU topics for Final FRCA
ICU topics for Final FRCAICU topics for Final FRCA
ICU topics for Final FRCA
 
Congenital Heart Disease for Anaesthesia
Congenital Heart Disease for AnaesthesiaCongenital Heart Disease for Anaesthesia
Congenital Heart Disease for Anaesthesia
 
Pulmonary embolism
Pulmonary embolismPulmonary embolism
Pulmonary embolism
 
ECLAMPSIA
ECLAMPSIA ECLAMPSIA
ECLAMPSIA
 
Hypertensive Crises.pptx
Hypertensive Crises.pptxHypertensive Crises.pptx
Hypertensive Crises.pptx
 
hypertensivecrises-221217080320-c743c113.pptx
hypertensivecrises-221217080320-c743c113.pptxhypertensivecrises-221217080320-c743c113.pptx
hypertensivecrises-221217080320-c743c113.pptx
 
Hypertensive Crises.pptx
Hypertensive Crises.pptxHypertensive Crises.pptx
Hypertensive Crises.pptx
 
BPH case undergoing TURP
BPH case undergoing TURPBPH case undergoing TURP
BPH case undergoing TURP
 
ICU Topics for the Final FRCA
ICU Topics for the Final FRCAICU Topics for the Final FRCA
ICU Topics for the Final FRCA
 
Stroke
StrokeStroke
Stroke
 
Pulmonary embolism
Pulmonary embolismPulmonary embolism
Pulmonary embolism
 
A Case of Infective Endocarditis
A Case of Infective EndocarditisA Case of Infective Endocarditis
A Case of Infective Endocarditis
 
Shock
ShockShock
Shock
 

More from Edward Fohrman

Intro to Neuromuscular Blockers
Intro to Neuromuscular BlockersIntro to Neuromuscular Blockers
Intro to Neuromuscular Blockers
Edward Fohrman
 
Edward Fohrman | Anesthesia for Pituitary Surgery
Edward Fohrman | Anesthesia for Pituitary SurgeryEdward Fohrman | Anesthesia for Pituitary Surgery
Edward Fohrman | Anesthesia for Pituitary Surgery
Edward Fohrman
 
Edward Fohrman | Anesthetic Considerations for Intracranial Tumors
Edward Fohrman | Anesthetic Considerations for Intracranial TumorsEdward Fohrman | Anesthetic Considerations for Intracranial Tumors
Edward Fohrman | Anesthetic Considerations for Intracranial Tumors
Edward Fohrman
 
Edward Fohrman | Neuroanesthesia in Neurotrauma
Edward Fohrman | Neuroanesthesia in NeurotraumaEdward Fohrman | Neuroanesthesia in Neurotrauma
Edward Fohrman | Neuroanesthesia in Neurotrauma
Edward Fohrman
 
Edward Fohrman | Introduction to Neuroanesthesia
Edward Fohrman | Introduction to NeuroanesthesiaEdward Fohrman | Introduction to Neuroanesthesia
Edward Fohrman | Introduction to Neuroanesthesia
Edward Fohrman
 
Edward Fohrman | Anesthetic Considerations for Carotid Endarterectomy
Edward Fohrman | Anesthetic Considerations for Carotid EndarterectomyEdward Fohrman | Anesthetic Considerations for Carotid Endarterectomy
Edward Fohrman | Anesthetic Considerations for Carotid Endarterectomy
Edward Fohrman
 
Edward Fohrman | Neurologic and Neuromuscular Disease in Pregnancy
Edward Fohrman | Neurologic and Neuromuscular Disease in PregnancyEdward Fohrman | Neurologic and Neuromuscular Disease in Pregnancy
Edward Fohrman | Neurologic and Neuromuscular Disease in Pregnancy
Edward Fohrman
 
Edward Fohrman | Anesthetic Considerations in Vascular Neurosurgery
Edward Fohrman | Anesthetic Considerations in Vascular Neurosurgery Edward Fohrman | Anesthetic Considerations in Vascular Neurosurgery
Edward Fohrman | Anesthetic Considerations in Vascular Neurosurgery
Edward Fohrman
 
Edward Fohrman | Neuroanesthesia for Cerebral Arteriovenous Malformations
Edward Fohrman | Neuroanesthesia for Cerebral Arteriovenous MalformationsEdward Fohrman | Neuroanesthesia for Cerebral Arteriovenous Malformations
Edward Fohrman | Neuroanesthesia for Cerebral Arteriovenous Malformations
Edward Fohrman
 

More from Edward Fohrman (9)

Intro to Neuromuscular Blockers
Intro to Neuromuscular BlockersIntro to Neuromuscular Blockers
Intro to Neuromuscular Blockers
 
Edward Fohrman | Anesthesia for Pituitary Surgery
Edward Fohrman | Anesthesia for Pituitary SurgeryEdward Fohrman | Anesthesia for Pituitary Surgery
Edward Fohrman | Anesthesia for Pituitary Surgery
 
Edward Fohrman | Anesthetic Considerations for Intracranial Tumors
Edward Fohrman | Anesthetic Considerations for Intracranial TumorsEdward Fohrman | Anesthetic Considerations for Intracranial Tumors
Edward Fohrman | Anesthetic Considerations for Intracranial Tumors
 
Edward Fohrman | Neuroanesthesia in Neurotrauma
Edward Fohrman | Neuroanesthesia in NeurotraumaEdward Fohrman | Neuroanesthesia in Neurotrauma
Edward Fohrman | Neuroanesthesia in Neurotrauma
 
Edward Fohrman | Introduction to Neuroanesthesia
Edward Fohrman | Introduction to NeuroanesthesiaEdward Fohrman | Introduction to Neuroanesthesia
Edward Fohrman | Introduction to Neuroanesthesia
 
Edward Fohrman | Anesthetic Considerations for Carotid Endarterectomy
Edward Fohrman | Anesthetic Considerations for Carotid EndarterectomyEdward Fohrman | Anesthetic Considerations for Carotid Endarterectomy
Edward Fohrman | Anesthetic Considerations for Carotid Endarterectomy
 
Edward Fohrman | Neurologic and Neuromuscular Disease in Pregnancy
Edward Fohrman | Neurologic and Neuromuscular Disease in PregnancyEdward Fohrman | Neurologic and Neuromuscular Disease in Pregnancy
Edward Fohrman | Neurologic and Neuromuscular Disease in Pregnancy
 
Edward Fohrman | Anesthetic Considerations in Vascular Neurosurgery
Edward Fohrman | Anesthetic Considerations in Vascular Neurosurgery Edward Fohrman | Anesthetic Considerations in Vascular Neurosurgery
Edward Fohrman | Anesthetic Considerations in Vascular Neurosurgery
 
Edward Fohrman | Neuroanesthesia for Cerebral Arteriovenous Malformations
Edward Fohrman | Neuroanesthesia for Cerebral Arteriovenous MalformationsEdward Fohrman | Neuroanesthesia for Cerebral Arteriovenous Malformations
Edward Fohrman | Neuroanesthesia for Cerebral Arteriovenous Malformations
 

Recently uploaded

India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
Kumar Satyam
 
Myopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptxMyopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptx
RitonDeb1
 
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
o6ov5dqmf
 
Health Education on prevention of hypertension
Health Education on prevention of hypertensionHealth Education on prevention of hypertension
Health Education on prevention of hypertension
Radhika kulvi
 
The Impact of Meeting: How It Can Change Your Life
The Impact of Meeting: How It Can Change Your LifeThe Impact of Meeting: How It Can Change Your Life
The Impact of Meeting: How It Can Change Your Life
ranishasharma67
 
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
ILC- UK
 
The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........
TheDocs
 
10 Ideas for Enhancing Your Meeting Experience
10 Ideas for Enhancing Your Meeting Experience10 Ideas for Enhancing Your Meeting Experience
10 Ideas for Enhancing Your Meeting Experience
ranishasharma67
 
How many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdfHow many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdf
pubrica101
 
CONSTRUCTION OF TEST IN MANAGEMENT .docx
CONSTRUCTION OF TEST IN MANAGEMENT .docxCONSTRUCTION OF TEST IN MANAGEMENT .docx
CONSTRUCTION OF TEST IN MANAGEMENT .docx
PGIMS Rohtak
 
HEAT WAVE presented by priya bhojwani..pptx
HEAT WAVE presented by priya bhojwani..pptxHEAT WAVE presented by priya bhojwani..pptx
HEAT WAVE presented by priya bhojwani..pptx
priyabhojwani1200
 
ICH Guidelines for Pharmacovigilance.pdf
ICH Guidelines for Pharmacovigilance.pdfICH Guidelines for Pharmacovigilance.pdf
ICH Guidelines for Pharmacovigilance.pdf
NEHA GUPTA
 
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Guillermo Rivera
 
ventilator, child on ventilator, newborn
ventilator, child on ventilator, newbornventilator, child on ventilator, newborn
ventilator, child on ventilator, newborn
Pooja Rani
 
CANCER CANCER CANCER CANCER CANCER CANCER
CANCER  CANCER  CANCER  CANCER  CANCER CANCERCANCER  CANCER  CANCER  CANCER  CANCER CANCER
CANCER CANCER CANCER CANCER CANCER CANCER
KRISTELLEGAMBOA2
 
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
The Lifesciences Magazine
 
India Diagnostic Labs Market: Dynamics, Key Players, and Industry Projections...
India Diagnostic Labs Market: Dynamics, Key Players, and Industry Projections...India Diagnostic Labs Market: Dynamics, Key Players, and Industry Projections...
India Diagnostic Labs Market: Dynamics, Key Players, and Industry Projections...
Kumar Satyam
 
Surgery-Mini-OSCE-All-Past-Years-Questions-Modified.
Surgery-Mini-OSCE-All-Past-Years-Questions-Modified.Surgery-Mini-OSCE-All-Past-Years-Questions-Modified.
Surgery-Mini-OSCE-All-Past-Years-Questions-Modified.
preciousstephanie75
 
Tips for Pet Care in winters How to take care of pets.
Tips for Pet Care in winters How to take care of pets.Tips for Pet Care in winters How to take care of pets.
Tips for Pet Care in winters How to take care of pets.
Dinesh Chauhan
 
Navigating Women's Health: Understanding Prenatal Care and Beyond
Navigating Women's Health: Understanding Prenatal Care and BeyondNavigating Women's Health: Understanding Prenatal Care and Beyond
Navigating Women's Health: Understanding Prenatal Care and Beyond
Aboud Health Group
 

Recently uploaded (20)

India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
 
Myopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptxMyopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptx
 
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
 
Health Education on prevention of hypertension
Health Education on prevention of hypertensionHealth Education on prevention of hypertension
Health Education on prevention of hypertension
 
The Impact of Meeting: How It Can Change Your Life
The Impact of Meeting: How It Can Change Your LifeThe Impact of Meeting: How It Can Change Your Life
The Impact of Meeting: How It Can Change Your Life
 
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
 
The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........
 
10 Ideas for Enhancing Your Meeting Experience
10 Ideas for Enhancing Your Meeting Experience10 Ideas for Enhancing Your Meeting Experience
10 Ideas for Enhancing Your Meeting Experience
 
How many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdfHow many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdf
 
CONSTRUCTION OF TEST IN MANAGEMENT .docx
CONSTRUCTION OF TEST IN MANAGEMENT .docxCONSTRUCTION OF TEST IN MANAGEMENT .docx
CONSTRUCTION OF TEST IN MANAGEMENT .docx
 
HEAT WAVE presented by priya bhojwani..pptx
HEAT WAVE presented by priya bhojwani..pptxHEAT WAVE presented by priya bhojwani..pptx
HEAT WAVE presented by priya bhojwani..pptx
 
ICH Guidelines for Pharmacovigilance.pdf
ICH Guidelines for Pharmacovigilance.pdfICH Guidelines for Pharmacovigilance.pdf
ICH Guidelines for Pharmacovigilance.pdf
 
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
 
ventilator, child on ventilator, newborn
ventilator, child on ventilator, newbornventilator, child on ventilator, newborn
ventilator, child on ventilator, newborn
 
CANCER CANCER CANCER CANCER CANCER CANCER
CANCER  CANCER  CANCER  CANCER  CANCER CANCERCANCER  CANCER  CANCER  CANCER  CANCER CANCER
CANCER CANCER CANCER CANCER CANCER CANCER
 
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
 
India Diagnostic Labs Market: Dynamics, Key Players, and Industry Projections...
India Diagnostic Labs Market: Dynamics, Key Players, and Industry Projections...India Diagnostic Labs Market: Dynamics, Key Players, and Industry Projections...
India Diagnostic Labs Market: Dynamics, Key Players, and Industry Projections...
 
Surgery-Mini-OSCE-All-Past-Years-Questions-Modified.
Surgery-Mini-OSCE-All-Past-Years-Questions-Modified.Surgery-Mini-OSCE-All-Past-Years-Questions-Modified.
Surgery-Mini-OSCE-All-Past-Years-Questions-Modified.
 
Tips for Pet Care in winters How to take care of pets.
Tips for Pet Care in winters How to take care of pets.Tips for Pet Care in winters How to take care of pets.
Tips for Pet Care in winters How to take care of pets.
 
Navigating Women's Health: Understanding Prenatal Care and Beyond
Navigating Women's Health: Understanding Prenatal Care and BeyondNavigating Women's Health: Understanding Prenatal Care and Beyond
Navigating Women's Health: Understanding Prenatal Care and Beyond
 

Edward Fohrman | Postanesthesia Recovery

  • 1. Edward B. Fohrman M.D Assistant Professor, Department of Anesthesiology Northwestern University, Feinberg School of Medicine POSTANESTHESIA RECOVERY
  • 2. CASE ▪ 55 y.o. male s/p robotic prostatectomy otherwise uneventful… ▪ Surgery is over ▪ Volatile agent is off ▪ Reversal given ▪ HOW DO U KNOW WHEN PT. IS READY FOR EXTUBATION???
  • 3. EXTUBATION CRITERIA? ▪ PaO2/FiO2 > 300 ▪ PaCO2 < 50 mmHg ▪ Vd/Vt < 0.6 ▪ RR < 35 ▪ Vt > 5 ml/kg ▪ NIF > (-20 mm H20) ▪ TOF ratio > 0.9 ▪ Clinical Strength (5 sec head lift) ▪ Mental Status c/w ability to maintain airway ▪ No Airway Edema/Vocal cord paralysis or other cause of airway obstruction ▪ Hemodynamic Stability
  • 4. When to transfer to PACU? ▪ ABC’s ▪ Patent or secure airway ▪ Adequate Oxygenation & Ventilation ▪ Hemodynamically stable
  • 5. O2 During Transport? 1) <93% after extubated in OR 2) Unconscious 3) Age > 60 4) Wgt > 100 kg 5) Pulmonary disease 6) Difficult airway 7) OSA 8) Surgery: Abd., Thoracic, Neuro, Cardiac, ENT 9) N2O (avoid diffusion hypoxia) 10) SpO2 < 93% upon arrival to PACU Probably NOT necessary in LOW RISK patient population… “Favor using O2 in anyone who’s physiology would be negatively affected by even a brief hypoxemic episode”
  • 6. How much O2 R U giving? Each liter of Nasal Cannula O2 increases FiO2 by 3 - 4% (Starting from room air 21%) Nasal cannula does not suppress respiratory drive even in COPD It is impossible to deliver more than 40% FiO2 with N.C. due to limitations in flow dynamics *DELIVERY OF 100% O2 can only be achieved with INTUBATION!!! Short of this, the highest O2 delivery can be achieved with a high flow, 10L “Nonrebreather” Face mask ≈ 90% FiO2 Miller’s Anesthesia 6th Ed. 2005
  • 7. Admission to the PACU ▪ Patient’s name & age ▪ Surgical procedure/Anes type ▪ Coexisting medical probs ▪ Allergies ▪ Fluids: EBL, IVF, UOP ▪ Anes/Surgical complications ▪ (difficult airway?) ▪ Special requests: meds, labs, x-rays ▪ Lines/Location (a-line, iv’s, epidural)
  • 8. Early Post-Op Physiologic Disorders ▪ Upper Airway Obstruction ▪ Arterial Hypoxemia ▪ Hypoventilation ▪ Hypotension ▪ Hypertension ▪ Cardiac Dysrhythmias ▪ Oliguria ▪ Bleeding ▪ Hypothermia ▪ Agitation/ Emergence Delirium ▪ Delayed Awakening ▪ Nausea & Vomiting
  • 9. Case ▪ 52 y.o. male s/p C4-6 ACDF brought to PACU after extubation ▪ 20 min later to inform u patient is tachypneic with SpO2 91 ▪ DDX? ▪ What else do you want to know? ▪ What’s your next move???
  • 10. Case ▪ 8 y.o. male s/p inguinal hernia repair brought to PACU after deep extubation ▪ The patient suddenly bucks and begins to desaturate rapidly…DDX? Treatment? ▪ What is Stage 2 anesthesia and why is it significant? ▪ How do you know when a patient is in stage 2 anesthesia?
  • 11. Upper Airway Obstruction ▪ Loss of pharyngeal muscle tone ▪ Obstructive Sleep Apnea (OSA) ▪ Laryngospasm ▪ Deep extubation? / Tx? ▪ Airway edema ▪ ↑IVF, ↑EBL, ↑Duration, Prone position ▪ Surgery of tongue, pharynx, neck, thyroid, CEA ▪ CUFF TEST ▪ Neck hematoma ▪ Monitor airway patency during transport – (Look, Listen, Feel)
  • 12. Residual Neuromuscular Blockade ▪ Assessment of adequate reversal? ▪ TOF, DBS, Clinical sx ▪ What factors increase risk of residual block? ▪ Drugs – Volatiles, local, Antiarrhythmics, Antibiotics, Corticosteroids, CCB’s, Dantrolene, Lasix, BCP’s ▪ Metabolic Physiologic states - ↑Mg, ↓Ca, Hypothermia, acidosis, liver/ renal failure, Myasthenia Gravis, Extremes of age ▪ Prolonged Depolarizing block ▪ Atypical pseudocholinesterase, Phase II block, Pregnancy, Echothiophate (irreversible), Edro, Neo, Pyrido (reversible)
  • 13. Classification of NMB’s Depolarizing ▪ Succinylcholine Nondepolarizing ➢ Short Acting ➢Mivacurium ➢Rapacuronium ➢ Intermediate Acting ➢Rocuronium ➢Vecuronium ➢Cisatracurium ➢Atracurium ➢ Long Acting ➢Pancuronium
  • 14. Case ▪ You just “deep” extubated your patient to avoid bucking on the tube after an otoplasty. As you are moving the patient to the gurney, the patient bucks and coughs and begins to turn blue. ▪ More good news…your IV was inadvertantly pulled out during the move and is now dripping on the O.R. floor… ▪ What’s the problem and how are you going to save the day?
  • 15. Succinylcholine • 2 Ach molecules linked by methyl groups • Agonist action binds the alpha subunit and leads to muscle contraction and refractory period • Depolarizing block also called Phase I block • Intubating dose: 1-1.5mg/kg (ED95 = 0.3mg/kg) • Onset 30-60 secs and duration 5-10 minutes • Defasciculating dose of nondepolarizer • (5-10% of ED95 2-4 min prior) must increase sux dose by 70% •Repeated doses > 3-5mg/kg >>> Phase II block •Serum potassium (K+) by 0.5 to 1 mEq/L • EJnAchR’s increase K+ ???
  • 16. Why Sux is unique? ▪ The only Depolarizing blocker used clinically today ▪ Most rapid onset of any other NMB ▪ Most rapid recovery/offset of any NMB ▪ Most significant degree of vocal cord paralysis/BEST intubating conditions ▪ Only NMB with rapid effects when given I.M. in cases of no IV access…IM dose?
  • 17. Each of the following patients requires urgent intubation…what do they all have in common???
 
 75 y.o. male s/p ischemic CVA 3 weeks ago with residual left hemiparesis
 
 21 y.o. female PMH - MVA 4 years ago with incomplete T4 level – urosepsis/pneumonia and SpO2 89%
 
 18 y.o. male s/p GSW to head, in barb coma w/ vecuronium gtt x 7 days who was inadvertantly extubated by the RN…

  • 18. Sux: Adverse side effects ▪ Hyperkalemia!!! ▪ Note: 1mg/kg Sux does NOT increase ICP (Kovarik et al. Anesthesia&Analgesia, 1994;78:469-73 ▪ Myoglobuinuria – Malignant Hyperthermia (MH) ▪ Cardiac dysrhythmias (esp. 2nd dose!) ▪ Sinus brady, Jct brady, Sinus arrest ▪ Fasciculations ▪ Myalgia (especially in outpatients) ▪ Increased intraocular pressure (not more than bucking) ▪ Increased intragastric pressure ▪ Trismus - Masseter muscle rigidity common in peds (4%) ▪ Associated with subsequent development of MH
  • 20. Effect of Sux on denervated muscle Martin and Richtsfeld, Anesthesiology, 2006;104:158-69
  • 21. Up/Down Regulation of nAChR Martin and Richtsfeld, Anesthesiiology, 2006;104:158-69
  • 22. ▪ 22 y.o. 70 kg. male without significant PMH/PSH undergoes a RSI for acute appendicitis. 10 min after 1mg/kg of sux, the patient receives a 30mg dose of ROC. ▪ The case goes well and the surgeon begins skin closure. ▪ TOF reveals that the patient still has no twitches 1 hour after the last dose of ROC….WHY? CASE
  • 23. Atypical Cholinesterase ▪ Check TOF after sux, (before NDNMB) ▪ Dx after a patient has a prolonged response to sux or mivacurium (>1hour) ▪ Dibucaine Number ▪ Dibucaine – amide local anesthetic ▪ Inhibits normal enzyme by 80% ▪ Inhibits abnormal enzyme by only 20%
  • 24. Variants of Plasma Cholinesterase and Duration of action of Succinylcholine Variants of Plasma Cholinesterase Incidence Dibucaine Number (% Inhibition of enzyme activity) Duration of succinylcholine induced neuromuscular blockade (min) Homozygous Typical Normal 70-80 5-10 Heterozygous 1 in 480 50-60 20 Homozygous Atypical 1 in 3200 20-30 60-180 Stoelting & Miller, Basics of Anesthesia. 2007
  • 25. Martin and Richtsfeld, Anesthesiology, 2006;104:158-69
  • 26. Arterial Hypoxemia ▪ R > L Shunt ▪ Atelectasis ▪ V/Q Mismatch ▪ ↓FRC ▪ CHF ▪ Pulmonary Edema ▪ Alveolar Hypoventilation ▪ Drugs: (NMBs, Narcotics,Volatiles) ▪ Increased CO2 production/ COPD ▪ Suboptimal ventilatory mechanics ▪ Aspiration ▪ PE ▪ PTX ▪ ↑O2 Consumption ▪ Shivering ▪ Sepsis ▪ TRALI ▪ ARDS ▪ Advanced age ▪ Obesity ▪ Diffusion Hypoxia
  • 27. 6 Causes of Arterial Hypoxemia 1. Low FiO2 2. Hypoventilation ▪ Muscle relaxants, narcotics, pain/splinting ▪ PAO2 = FiO2(PB760-PH2047) – (PCO2/RQ)
  • 28. Arterial Hypoxemia 3. Shunt V/Q = 0 (Absolute shunt) ▪ perfusion without ventilation ▪ PTX, bronchial intubation/single lung ventilation, R>L cardiac shunt, ARDS/sepsis, liver failure, AVM, atelectasis, pneumonia/mucous plugging, pulmonary contusion, bronchospasm, CHF ▪ Shunted blood is NOT exposed to alveoli, thus O2 unresponsive for shunt > 30% ▪ Shunt fraction = Qs/Qt = CcO2-CaO2/CcO2-CvO2 ▪ 2 sources of normal shunt: Bronchial arteries and thebesian veins. (Normally 2-5%)
  • 29. Arterial Hypoxemia 4. V/Q Mismatch V/Q = ∞ Dead space: ventilation without perfusion V/Q>1 i.e. Pulmonary Embolus V/Q matching optimally should be 1:1 Hypoxic Pulmonary Vasoconstriction (HPV) 5. Diffusion defects Advanced pulmonary disease, pulmonary edema, ARDS 6. ↑Venous Admixture (Low cardiac output states) O2 Delivery = O2 content x Cardiac Output O2 Content = 1.34 x Hgb x SaO2 + (PaO2 x 0.003) Decreased CO, ↑ O2 consumption, Anemia, Hgb dysfct.
  • 30. Shunt – Response to O2 ▪ Increasing FiO2 from room air to 100% results in a large increase in PaO2 when the shunt fraction is small; however, oxygen will have little effect on PaO2 in patients with a large shunt fraction Miller’s Anesthesia 6th Edition, 2005
  • 31. Case ▪ 38 y.o. female s/p scoliosis repair is brought to the ICU intubated. ▪ You note SpO2 of 89% and absent BS on the Left chest ▪ You ask for a stat CXR for line placement (left SCV cordis) ▪ What’s your next move???
  • 32. Pulmonary Edema ▪ Fluid Overload ▪ Iatrogenic: Large IVF, Blood transfusions (TACO) ▪ ESRD/CRF ▪ Cardiogenic/CHF ▪ MI, Arrhythmia, Valvular lesion ▪ Euvolemic ▪ ARDS ▪ Catecholamine surge ▪ Neurogenic/SAH ▪ TRALI (up to 6hr post tx delay, leukopenia) ▪ Negative Pressure Pulmonary Edema
  • 33. Reintubation in PACU? ▪ PaO2/FiO2 ratio < 300 ▪ Respiratory rate > 35 breaths/minute ▪ Tidal Volume Vt < 5 cc/kg ▪ Vital capacity <15ml/kg (adults) <10ml/kg (peds) ▪ Negative inspiratory force of < -20 mmHg ▪ PaO2 < 70 mmHg on 40% FiO2 ▪ PaCO2 > 55-60 mmHg (except chronic CO2 retainers i.e.COPD) ▪ Alveolar-arterial (A-a) gradient > 350 mmHg on 100% FiO2 ▪ Dead Space (VD/VT) > 0.6 ▪ Hemodynamic instability? ▪ WHAT DOES THE PATIENT LOOK LIKE???
  • 34. Case ▪ 68 y.o. male s/p RLL Lobectomy under GA, Thoracic epidural, Dbl lumen ETT, now extubated to PACU ▪ BP 70/40, HR 120, SpO2 93% ▪ DDX? ▪ What’s your next move???
  • 35. HYPOTENSION BP = CO x SVR CO = SV x HR SVR = MAP- CVP CO Preload Afterload Cardiac Contractility
  • 36. Hypotension ▪ ↓Intravascular Volume (Preload) ▪ (PCWP<5-10mmHg) with normal CI (2.5-4.0) ▪Bleeding! ▪Bleeding!! ▪Bleeding!!! ▪3rd Spacing ▪Insensible losses
  • 37. Hypotension ▪ ↓Cardiac Output (Intrinsic pump failure) ▪CO = HR x SV (CI < 2.5) ▪ MI ▪ Cardiomyopathy ▪ Valvular Dz ▪ Pericardial Dz ▪ Tamponade ▪ Dysrhythmias ▪ PE ▪ Tension PTX ▪ Drugs (Beta Blockers, CCBs)
  • 38. Hypotension ▪ ↓Systemic Vascular Resistance (Afterload) ▪ SVR = (MAP-CVP/CO) x 80 (900 to 1400 dynes/ sec/cm-5) ▪ Sepsis / SIRS ▪ Anaphylaxis ▪ Spinal Shock (SCI, Epidural/High Spinal) ▪ Adrenal Insufficiency
  • 39. Case ▪ 68 y.o. male s/p Left CEA under GA now extubated to PACU ▪ BP 198/100, HR 61, SpO2 97% ▪ DDX? ▪ What’s your next move???
  • 40. Hypertension ▪ A-line transducer level? ▪ Emergence Excitement? ▪ Arterial Hypoxemia ▪ Enhanced Sympathetic Tone ▪ PAIN, PAIN, PAIN ▪ Hypoventilation/Hypercapnia ▪ Autonomic Hyperreflexia, Carotid surgery ▪ Bladder distention/ Gastric distention ▪ Essential HTN – Preop ▪ Hypervolemia/Fluid Overload ▪ Shivering ▪ Drugs/ Drug Rebound ▪ ↑ ICP ▪ Thyrotoxicosis, Pheochromocytoma
  • 41. Cardiac issues in PACU ▪ Risk factors for CAD ▪ Smoking ▪ HTN ▪ Hypercholesterolemia ▪ Diabetes Mellitus ▪ Obesity ▪ Physical Inactivity ▪ Family History ▪ (1st order relative prior to age 55) Identify patients at risk!
  • 42. ECG ∆’s in PACU ▪ Low Risk Patient ? ▪ Age < 45 ▪ No known Cardiac History ▪ Only 1 Cardiac Risk Factor ▪ Post op ST ∆’s = MI? Usually NOT ▪ Usually benign and do not require more than routine PACU observation unless associated dysrhythmia and/or hemodynamic instability DON’T DO A MILLION $ Work UP!!!
  • 43. ECG ∆’s (High Risk) ▪ Who is High Risk? ▪ Post op ST and T ∆’s may be significant even in the absence of typical sx ▪ 12 lead ECG (vs. preop ECG) ▪ Serial Troponin-I (cTni), CBC, Chem, ABG ▪ O2, NTP/NTG, Beta Blockade ▪ If BP unstable ▪ consider re-intubation/echo/PA catheter/Inotropes ▪ Notify primary service/ discuss your concerns ▪ Cardiology consult/ follow-up ▪ Disposition – Tele, ICU, floor?
  • 44. Cardiac Dysrhythmias ▪ Hypoxemia ▪ Hypercarbia ▪ Volume Shifts/Fluid Overload ▪ Myocardial Ischemia ▪ Electrolyte Abnormalities ▪ Acidosis ▪ Anemia ▪ Pain, Agitation, Hypothermia ▪ HTN ▪ Preoperative Cardiac Dysrhythmia ▪ Drugs/ Withdrawal ▪ Digoxin Toxicity ▪ Anticholinesterases ▪ Anticholinergics ▪ PE ▪ PTX/Line placement ▪ SIRS ▪ MH ▪ Thyroid storm/Pheo
  • 45. Case ▪ 44 y.o. male patient s/p appy ▪ 5 minutes after giving report, the patient’s HR is 40… ▪ What else do you want to know? ▪ What are you going to do?
  • 46. Atrial Dysrhythmias ▪ Noncardiac Surgery (10%) ▪ Cardiothoracic Surgery (25-30%) ▪ Associated with longer hospital stay and higher mortality ▪ Electrical Cardioversion vs. ctrl Ventricular response – CCB, β-Blockade, Amiodarone ▪ Vagal maneuvers, adenosine to distinguish between SVT and A-fib/flutter
  • 47. Ventricular Dysrhythmias ▪ PVC’s, Ventricular Bigeminy are common, but rarely degenerate into V-tach ▪ PVC’s may just reflect ↑ sympathetic stim. (hypercapnia, intubation) ▪ Multifocal PVC’s vs. Unifocal PVC’s? ▪ Consider ABG, CBC, Chem, cTni if suspect myocardial ischemia – Torsades, QT prolongation? ▪ Electrical Cardioversion vs. Amiodarone
  • 48. Case ▪ 81 y.o. male s/p Right Hip Pinning under GA, now extubated to PACU ▪ Mr. Cartman is confused… ▪ DDX? ▪ What’s your next move?
  • 49. Delirium ▪ An acute change in cognition or disturbance of consciousness that cannot be attributed to a preexisting medical condition , substance intoxication, or medication. ▪ 10% Incidence: > 50 y.o. undergoing elective surgery up to POD #5 ▪ Higher incidence (30%) after Hip ORIF and Bilateral TKR
  • 50. Risk Factors: Post-Op Delirium ▪ Advanced age ▪ Preoperative cognitive impairment ▪ Decreased functional status ▪ ETOH abuse ▪ History of delirium
  • 51. Management of Post-Op Delirium ▪ Vitals! ▪ Patient Safety ▪ Restraints ▪ Physical ( soft restraint/full restraint) ▪ Chemical (Versed, Physostigmine, Antipsychotics (Haldol) ▪ Even if it means Reintubation! ▪ Work-UP Etiology…
  • 52. DDX Delirium ▪ Arterial Hypoxemia ▪ Preexisting Cognitive Disorder ▪ Dementia, Parkinson’s vs. conversion rxn ▪ Hypoventilation/Hypercapnia ▪ Metabolic Derangements ▪ Renal/Hepatic insufficiency, Acidosis, Electrolyte abnormalities ▪ Drugs ▪ Anticholinergics, BDZ’s, Opioids, β-Blockers, Reglan ▪ CNS ▪ Ischemic/Hemorrhagic CVA, Seizures ▪ Infection/SIRS ▪ Emergence Excitement: ▪ 30% of peds, peak age 2-4 y.o.
  • 53. Case ▪ 49 y.o. male s/p ex-lap for perforated diverticulitis under GA, now extubated to PACU ▪ Patient has no urine output from the foley ▪ DDX? ▪ What’s your next move?
  • 54. Oliguria ▪ Most commonly “pre-renal” from depletion of intravascular volume ▪ Usually responds to a 500-1000ml bolus ▪ Check Hct to rule out surgical bleeding ▪ d/w surgeon/?check bladder pressure to rule out intra- abdominal htn ▪ Intra-abdominal Pressure > 30cm H2O can impair renal perfusion ▪ Value of fractional excretion of sodium (FeNa) is limited in the PACU and confounded by diuretics ▪ In cases where the patient’s volume status and/or cardiac function is in question (MI, CHF, SIRS), consider placing a PA Catheter/or obtaining an echocardiogram
  • 55. Renal Dysfunction ▪ Oliguria (<0.5 ml/kg/hr) ▪ Preop vs. Intraop vs. Postop ▪ Usually multifactorial (i.e. Preexisting CRI confounded by an intraoperative insult) ▪ Focus on “treatable causes” in PACU Classification • Prerenal • Renal • Postrenal
  • 56. Postoperative Oliguria ▪ Prerenal ▪ Hypovolemia ▪Bleeding, Bleeding, Bleeding ▪3rd Spacing, Insensible losses ▪Inadequate volume resuscitation ▪ Hepatorenal syndrome ▪ Low Cardiac Index (MI, CHF,) ▪ SIRS ▪ Renal Vascular Obstruction/ Disruption ▪ Abdominal Compartment Syndrome
  • 57. Postoperative Oliguria ▪ Renal ▪ Ischemia (ATN) ▪ Contrast/IVP Dyes ▪ Rhabdomyolysis (Alkalinize urine/mannitol) ▪ Tumor lysis ▪ Hemolysis
  • 58. Postoperative Oliguria ▪ Postrenal ▪ Surgical injury to Ureter(s) ▪ Ureteral obstruction (Stone, Clots) ▪ Mechanical (Foley Catheter obstruction/Malposition
  • 59. Body Temperature & Shivering ▪ Postoperative shivering ▪ Incidence: 5%→65% ▪ Mechanism ▪ Hypothermia- thermoregulatory center ▪ Normothermia- more rapid recovery of spinal cord function, uninhibited spinal reflexes→ clonic activity ▪ Treatment ▪ Identification of hypothermia by core body temp ▪ Forced air warmers ▪ Opioids, Clonidine, Meperidine (most effective)
  • 60. Body Temperature & Shivering ▪ Clinical Effects ▪ Increases O2 consumption and CO2 production ▪ Increased CO, HR and BP ▪ Inhibition of platelet function, coagulation factor activity and drug metabolism ▪ Exacerbates postoperative bleeding, prolongs neuromuscular blockade, and may delay awakening ▪ Prolonged PACU stay ▪ Long Term: increased incidence of myocardial ischemia/ infarction, delayed wound healing, increased perioperative mortality
  • 61. PONV ▪ Incidence: 10%→80% ▪ Delayed Discharge ▪ Unanticipated Admission ▪ Pulmonary Aspiration ▪ Post-operative discomfort
  • 62. PONV RISK ▪ High Risk Patients ▪ Female ▪ History of Motion sickness/PONV ▪ Nonsmoker ▪ Intra/Postoperative opioids ▪ Peds ▪ Other Risk Factors ▪ Obesity ▪ Anxiety ▪ Gastroparesis/ Gastric distension ▪ GERD ▪ Dehydration ▪ Type of Surgery (eye muscle, middle ear, laparoscopic, Breast, Plastics) ▪ Anesthetic Drugs (Volatile 0-2hrs, N2O, NMB Reversal?) Consensus Guidelines for Managing PONV, Anesth & Analg 7/2003
  • 63. PONV ▪ For every 30 minutes of inhalational anesthesia, there is a 60% increase in PONV risk… Consensus Guidelines for Managing PONV, Anesth & Analg 7/2003
  • 64. PONV ▪ Serotonin (5-HT3) Antagonists (Ondansetron) ▪ Effective when given 30min before end of case ▪ Corticosteroids (Dexamethasone) ▪ Replaced droperidol for 1st line prophylaxis, unknown mechanism (reduce prostaglandins) ▪ Anticholinergics (Scopolamine) ▪ Antihistamines (Hydroxyzine) ▪ Prokinetic (Promethazine) ▪ Butyrophenones (Droperidol) ▪ Very effective, FDA Warning 6/2001, 6 hour monitoring for cardiac dysrhythmia (torsades de pointes)
  • 65. Treatment PONV ▪ Low Risk Patients ▪ Dexamethasone prophylaxis ▪ Moderate Risk Patients ▪ Dexamethasone prophylaxis ▪ Serotonin Antagonists ▪ High Risk Patients ▪ Dexamethasone prophylaxis ▪ Seratonin Antagonists ▪ Prokinetic ▪ Very High Risk Patients ▪ Multimodal approach ▪ Aggressive IV Fluid ▪ Combination pharmacotherapy ▪ REGIONAL ANESTHESIA when possible ▪ TIVA ▪ Avoid: Opioids, inhalational agents/N2O, reversal agents
  • 66. Bleeding Abnormalities Test Normal Value Abnormality Platelet Count >150,000 cells/mm3 Dilutional, DIC Bleeding Time 3-10 min Platelet-inhibiting Rx Prothrombin Time 12-14 sec DIC, Vit K Def, Liver Dz, Coumadin Partial Thromboplastin Time 25-35 sec Factor V and VIII Def, Heparin, Heophilia Fibrinogen 200-400 mg/dL DIC Fibrin Split Products <4 µg/ml DIC TEG N/A Platelet and clotting factor deficiencies Platelet Fct Assay N/A Plt Adhesion & Aggregation
  • 67. Case ▪ You are the PACU resident of the week and the RN calls re: ▪“My patient in slot 12 isn’t waking up!” ▪ What else do you want to know? ▪ DDX?
  • 68. Delayed Awakening ▪ Possible explanations… ▪ Pharmacological ▪ Residual Drug Effect (Opioids, BDZ, anticholinergics) ***Most frequent cause ▪ Chemical (Metabolic) ▪ Hypoxemia, Hypercarbia, Hypoglycemia, Electrolyte abnormalities ▪ Physical ▪ Hypothermia (Temp < 33°C), Air Embolism ▪ Neurologic ▪ Increased ICP, Sz/Postictal, Hysteria?
  • 69. Delayed Awakening ▪ Evaluation ▪ VITAL SIGNS!!! ▪ Neurologic Exam ▪ ABG (oxygenation and ventilation) ▪ Additional labwork ▪ Electrolytes, glucose, etc.. ▪ Radiographic procedures (CT)
  • 70. Delayed Awakening ▪ Analgesic ▪ Opioids → Naloxone (20-40 µg increments) ▪ Short acting, reversal of analgesia, hypertension, arrhythmias, delerium ▪ Anesthetic - Hypnotic ▪ Benzodiazepines → Flumazenil (0.2mg IV over 15 sec, 0.3mg IV over 30 sec, 0.5mg IV over 30 sec) Side effect/Risk of seizures ▪ Akinetics ▪ Muscle Relaxants → Neostigmine
  • 71. Modified Aldrete Score D/C Criteria